Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort
Open Access
- 19 December 2018
- journal article
- review article
- Published by F1000 Research Ltd in F1000Research
- Vol. 7, 1184
Abstract
Background: Malignant mesothelioma (MM) is a rare but deadly malignancy with about 3,000 new cases being diagnosed each year in the US. Very few studies have been performed to analyze factors associated with mesothelioma survival, especially for peritoneal presentation. The overarching aim of this study is to examine survival of the cohort of patients with malignant mesothelioma enrolled in the National Mesothelioma Virtual Bank (NMVB). Methods: 888 cases of pleural and peritoneal mesothelioma cases were selected from the NMVB database, which houses over 1400 cases that were diagnosed from 1990 to 2017. Kaplan Meier’s method was performed for survival analysis. The association between prognostic factors and survival was estimated using Cox Hazard Regression method and using R software for analysis. Results:The median overall survival (OS) rate of all MM patients, including pleural and peritoneal mesothelioma cases is 15 months (14 months for pleural and 31 months for peritoneal). Significant prognostic factors associated with improved survival of malignant mesothelioma cases in this NMVB cohort were below the age of 45, female gender, epithelioid histological subtype, stage I, peritoneal occurrence, and had treatment that consisted of combining surgical therapy with chemotherapy. Combined surgical and chemotherapy treatment was associated with improved survival of 23 months in comparison to single line therapies. Conclusions:There has not been improvement in the overall survival for patients with malignant mesothelioma over many years with current available treatment options. Our findings show that combined surgical and chemotherapy treatment in peritoneal mesothelioma is associated with improved survival compared to local therapy alone.Keywords
Funding Information
- Centers for Disease Control and Prevention (5U24OH009077-11)
- National Institute for Occupational Safety and Health (5U24OH009077-11)
This publication has 28 references indexed in Scilit:
- Scientific Advances and New Frontiers in Mesothelioma TherapeuticsJournal of Thoracic Oncology, 2018
- Consensus Report of the 2015 Weinman International Conference on MesotheliomaJournal of Thoracic Oncology, 2016
- Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results databaseJournal of Surgical Research, 2015
- Asbestos is not just asbestos: an unrecognised health hazardThe Lancet Oncology, 2013
- Malignant mesothelioma: Facts, Myths, and HypothesesJournal of Cellular Physiology, 2011
- Survival of peritoneal malignant mesothelioma in Italy: A population‐based studyInternational Journal of Cancer, 2008
- Mesothelioma Epidemiology, Carcinogenesis, and PathogenesisCurrent Treatment Options in Oncology, 2008
- A review of peritoneal mesothelioma at the Washington Cancer InstituteSurgical Oncology Clinics of North America, 2003
- Peritoneal mesotheliomaCurrent Treatment Options in Oncology, 2002
- Latency of asbestos disease among insulation workers in the United States and CanadaCancer, 1980